| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 79.003 | 130.775 | 130.186 | 129.481 | 133.813 | 150.271 | 177.053 |
| Total Income - EUR | - | - | - | 79.004 | 130.777 | 132.256 | 129.483 | 145.374 | 150.272 | 177.055 |
| Total Expenses - EUR | - | - | - | 48.436 | 87.073 | 90.244 | 111.649 | 142.830 | 158.552 | 128.870 |
| Gross Profit/Loss - EUR | - | - | - | 30.568 | 43.704 | 42.012 | 17.834 | 2.543 | -8.280 | 48.185 |
| Net Profit/Loss - EUR | - | - | - | 29.778 | 42.396 | 40.810 | 16.565 | 1.119 | -9.557 | 42.980 |
| Employees | - | - | - | 1 | 1 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Ingrid Teo Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 1.987 | 2.322 | 911 | 145 | 0 | 4.711 |
| Current Assets | - | - | - | 34.565 | 69.894 | 47.342 | 62.691 | 33.324 | 42.499 | 63.986 |
| Inventories | - | - | - | 0 | 0 | 1.401 | 0 | 0 | 0 | 14.032 |
| Receivables | - | - | - | 12.191 | 13.299 | 12.352 | 18.595 | 19.208 | 30.355 | 28.003 |
| Cash | - | - | - | 22.374 | 56.595 | 33.589 | 44.097 | 14.117 | 12.144 | 21.952 |
| Shareholders Funds | - | - | - | 29.821 | 66.316 | 40.860 | 56.519 | 1.167 | -8.393 | 34.634 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 4.744 | 5.565 | 8.805 | 7.083 | 32.302 | 50.892 | 34.063 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Ingrid Teo Med S.r.l.